StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV)
StockNews.com assumed coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “neutral” rating and issued a $5.00 target price on shares of Minerva Neurosciences in a report on Wednesday, February 26th. […]
StockNews.com assumed coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “neutral” rating and issued a $5.00 target price on shares of Minerva Neurosciences in a report on Wednesday, February 26th. […]
